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Summary 
 
We investigated the molecular bases of spondyloepiphyseal dysplasia (SED) associated with the 
R992C (p.R1192C) substitution in collagen II. At the protein level we analyzed the structure and 
integrity of mutant molecules, and at the cellular level we specifically studied the effects of the 
presence of the R992C collagen II on the biological processes taking place in host cells. Our 
studies demonstrated that mutant collagen II molecules were characterized by altered 
electrophoretic mobility, relatively low thermostability, the presence of atypical disulfide bonds, 
and slow rates of secretion into the extracellular space. Analyses of cellular responses to the 
presence of the mutant molecules showed that excessive accumulation of thermolabile collagen 
II was associated with the activation of an “unfolded protein response” and an increase in 
apoptosis of host cells. Collectively, these data suggest that molecular mechanisms of SED may 
be driven not only by structural changes in the architecture of extracellular collagenous matrices, 
but also by intracellular processes activated by the presence of mutant collagen II molecules.  
 
Keywords: collagen II mutations; unfolded protein response; ER stress; extracellular matrix; 
apoptosis 
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Introduction 
 
 Collagen II, a main structural protein of cartilaginous tissues, is first synthesized as 
procollagen characterized by the presence of an extended triple-helical domain flanked by the 
globular N-terminal and C-terminal propeptides 1. Biosynthesis of procollagen molecules is a 
complex process that involves posttranslational modifications of the nascent pro-α chains. These 
modifications include hydroxylation of proline residues and lysine residues by prolyl-4 
hydroxylase (P4H) and lysyl hydroxylase (LH), respectively. Moreover, the posttranslational 
modifications and subsequent formation of the triple-helical structure are controlled by a group 
of endoplasmic reticulum (ER)-resident protein chaperones that includes heat shock protein 47 
(HSP47), immunoglobulin-binding protein (BiP), and protein disulfide isomerase (PDI), an 
enzyme that also acts as the β-subunit of the αα/ββ tetramer that constitutes functional P4H 
2,3,4,5
. In addition, by binding to the individual pro-α1(II) chains and preventing their premature 
association, P4H may also act as a chaperone during biosynthesis of procollagen molecules 6. 
Following biosynthesis of individual pro-α1(II) chains, their posttranslational modifications, and 
folding into triple-helical structure, procollagen molecules are released from the ER and directed 
toward secretory pathways.  
 A critical triple-helical domain of collagen II consists of α1(II) chains formed by about 330 
G-X-Y triplets in which the “X” position is frequently occupied by a proline residue and the “Y” 
position by a hydroxyproline residue. The importance of correct conformation of the triple-
helical region for the proper structure and function of skeletal tissues is clearly evidenced by a 
number of aberrations of these tissues caused by mutations in COL2A1 (OMIM# 120140). In 
particular, single amino acid substitutions in collagen II are responsible for a broad spectrum of 
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chondrodysplasia phenotypes, generally described as spondyloepiphyseal dysplasia (SED), 
whose main feature is abnormalities of skeletal development 1,7,8,9,10,11,12,13. The most frequent 
amino acid substitutions in collagen II occur at the “G” position of the G-X-Y triplets but 
substitutions in the “Y” positions were also described. For instance, a G853E (p.G1053E) 
substitution was found in a patient with a lethal form of SED, whereas cysteine substitutions for 
arginine residues were found in the “Y” positions 75 (p.R275C), 519 (p.R719C), and 789 
(p.R989C) in patients with a mild form of SED, a mild form of osteoarthritis, and a severe form 
of congenital SED, respectively 9,13,14,15. In addition to mutations found in the “G” and “Y” 
positions, relatively rare mutations in the “X” positions of the G-X-Y triplets were also reported 
in patients with Stickler syndrome, a disease characterized by myopia, cataracts, retinal 
detachment, hearing loss, and mild SED 13,16,17. 
 The molecular bases of tissue-level aberrations in patients with mutations in COL2A1 are 
not fully understood. It has been suggested that a key problem caused by amino acid 
substitutions in collagen II is that the mutant collagens cannot fulfill their structural functions. 
Studies demonstrated that a decrease in the overall content of collagen II and its inability to 
assemble into correct fibrils are the main factors causing such alterations of structural functions 
13,18,19,20,21
. In addition to affecting extracellular functions, it has been suggested that some 
mutations in collagen II cause excessive intracellular accumulation of misfolded mutant 
molecules and that such accumulation can lead to apoptosis of cells harboring mutant molecules 
22,23
.  
 Here, we studied the molecular and the cellular-level consequences of the R992C 
(p.R1192C) substitution in the “X” position of a G-X-Y triplet of collagen II. This mutation 
(p.R1147C) was originally described in mice, referred to as spondyloepiphyseal dysplasia 
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congenita or sedc mice in which skeletal abnormalities were similar to those seen in SED 
patients 24. Employing a system for expressing recombinant collagen II, we demonstrated that the 
R992C collagen II is characterized by aberrant electrophoretic mobility, relatively low 
thermostability, and the presence of intramolecular disulfide bonds. Moreover, we showed that 
the expression of the R992C collagen II is associated with ER stress and increased apoptosis of 
cells harboring this collagen mutant. 
 Results presented here contribute to understanding the molecular basis of mutation-triggered 
pathological changes seen at the level of skeletal tissues and suggest that mutations in collagen II 
that interfere with correct folding of the collagen triple helix are likely to act not only by 
disturbing the extracellular collagenous framework but also by altering intracellular processes. 
 
 
Results 
Analysis of R992C mutant. 
 To analyze mutant collagen molecules, we produced the green fluorescence protein (GFP)-
tagged wild type procollagen II (WT Pro-GFP) and R992C procollagen II (R992C Pro-GFP) in 
HT-1080 cells, as described 25. Electrophoresis of intact GFP-tagged procollagen molecules 
carried out in 6% polyacrylamide gels demonstrated that the electrophoretic mobility of the 
R992C Pro-GFP was slower than that of the WT Pro-GFP (Fig. 1). Similar differences in the 
electrophoretic mobilities were seen in pepsin-treated variants in which non-triple-helical 
propeptides were enzymatically degraded (Fig. 1). In addition to the intact α1(II) mutant chains, 
their degraded forms were inconsistently seen in different protein preparations (Fig. 1). The 
treatment of collagen II variants with glycosidases demonstrated that slower migration of the 
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R992C mutant was not caused by overglycosylation of mutant collagen α1(II) chains. In this 
experiment only a minor shift in the migration of glycosidase-treated wild type and mutant 
collagens was observed (Fig. 1). Such a minor shift in migration indicates relatively small levels 
of glycosylation of the α1(II) chains, an observation consistent with our previous report 25. Since 
no change in the electrophoretic migration of the R992C collagen treated with various denaturing 
agents was observed, we excluded atypical aggregation as the reason for the slow electrophoretic 
mobility of this protein (data not shown). Analysis of collagen chains separated in non-reducing 
conditions demonstrated that about 6% of α1(II) chains were covalently linked by disulfide 
bonds (Fig. 1). The identity of disulfide-linked chains was confirmed by separating α1(II) 
monomers and dimers in nonreducing conditions followed by electrophoresis of separated chains 
in the reducing conditions (Fig. 2). 
 
Analyses of thermostability of the R992C mutant. 
 Brief protease digestion of pepsin-treated collagen II demonstrated that the thermostability 
of the R992C mutant was lower than that of the control (Fig. 3). Specifically, we measured the 
temperatures at which the triple helical structure of analyzed collagens was preserved in 75% 
(Tm75), 50% (Tm50), and 25% (Tm25) of maximum. We determined that Tm75, Tm50, and Tm25 
for the R992C were 36.5°C, 39.9°C, and 42.0°C, respectively. Corresponding Tm75, Tm50, and 
Tm25 values for the WT collagen II were 40.0°C, 41.2°C, and 42.2°C, respectively.  In contrast 
to the wild type collagen II, protease digestion of the R992 mutant at about 36°C resulted in the 
generation of intermediate stable products (Fig. 3). 
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Computer modeling of the R992C mutation site. 
 To study the structural basis of formation of disulfide bonds we performed computer 
modeling of the region encompassing the C992 mutation site (Fig. 4). In this study the modeled 
collagen fragment consisted of three mutant α1(II) chains. Such a model provides good 
representation of the homotrimeric R992C collagen II produced in HT-1080 cells and in 
homozygotic mutant mice, in which the R992C mutation was associated with severe SED 24. 
Analysis of the model revealed that sulfhydryl groups of cysteine residues present in two α1(II) 
chains were spatially oriented in a way that enables formation of the disulfide bonds. Moreover, 
the model revealed that the sulfhydryl group of the free cysteine residue was exposed on the 
surface of a molecule, thereby rendering it available for formation of intermolecular disulfide 
bonds. In addition, analysis of molecular surfaces demonstrated that the cysteine for arginine 
substitution decreased the electrostatic potential (EP) of a region encompassing the mutation site. 
Specifically, the EP values (expressed in kcal/mol.e) for the region with a molecular surface area 
of about 1000 Å2 and encompassing the R992 residue ranged from 117.7 to 233.4. In contrast, 
the corresponding EP values for the analogous region encompassing the C992 site ranged from 
28.2 to 127.2. 
 
Unconditional and Tet-regulated expression of procollagen II variants in SW-1353 cells. 
 We generated a system for unconditional and tetracycline (Tet)-regulated expression of 
procollagen II variants. Procollagen II variants expressed unconditionally were denoted as “Pro-
GFP” whereas those expressed in the Tet-regulated fashion, as “Pro-GFPTet”. To account for 
possible differences in measured parameters, due to clonal variations in expression of the R992C 
mutant, two independent R992C Pro-GFP and two R992C Pro-GFPTet clones were analyzed in 
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more detail. The biosynthesis of procollagen II variants expressed in SW-1353 cells was 
characterized by Western blot and RT-PCR assays. As indicated in Fig. 5, procollagen II was 
efficiently expressed in both systems. Moreover, in the Tet-regulated system expression of 
procollagen II was efficiently expressed only in the presence of doxycycline (Dox). In one of the 
R992C Pro-GFPTet clones (clone #2) there was a detectable baseline-level expression of the 
R992C Pro-GFPTet mRNA. Such a baseline expression is expected due to nonspecific activation 
of a Tet-regulated cytomegalovirus (CMV) promoter 26. As indicated in Fig. 5 expression of 
procollagen variants was comparable at both the mRNA and protein levels. 
 In addition to analysis of the intracellular pool of the R992C collagen II, we also studied 
kinetics of secretion of this mutant in comparison to WT control (Fig. 6). Assays of Pro-GFP 
from two different clones harboring the R992C collagen II demonstrated that the secretion rate of 
this mutant, represented by the slope of a fitted curve, was slower in comparison to WT control. 
In particular, after six hours from the beginning of the experiment the relative amount of the 
R992 Pro-GFP present in the media was only about 40% of WT Pro-GFP secreted from the same 
number of cells. In all analyses of the secretion rates, the R2 values ranged from 0.9 to 1.0, 
indicating a satisfactory curve fit. 
 
Apoptotic markers in cells expressing R992C mutant. 
 Cellular apoptosis was assayed by TdT-mediated dUTP nick-end labeling (TUNEL) (Fig. 7) 
and measurements of the relative content of cleaved poly (ADP-ribose) polymerase (PARP) (Fig. 
8). In the TUNEL assays the apoptotic index was defined as the percentage of the TUNEL-
positive cells out of the total number of 4',6-diamidino-2-phenylindole (DAPI)-stained nuclei. 
The R992C Pro-GFP variant had a higher apoptotic index, corresponding to 4.2%±0.5%, than 
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the WT Pro-GFP with an apoptotic index of 2.2%±0.2%. Statistical analysis with the Student’s t 
test revealed that the difference between mean values for two groups was statistically significant 
(P=0.0042) (Fig. 7). To confirm that DNA fragmentation was a direct result of the presence of 
the R992C mutant, we employed cells conditionally expressing the R992C Pro-GFPTet variant. In 
the Tet-ON condition, in the presence of the R992C mutant, the apoptotic index (4.8%±0.4%) 
was significantly higher (P=0.0037) than in cells cultured in the Tet-OFF condition 
(3.2%±0.3%). In contrast, regardless of Tet-ON or Tet-OFF conditions, apoptotic indexes for 
cells engineered to express the WT Pro-GFPTet did not show any significant difference 
(P=0.4744). 
 Multiple analyses of two different clones expressing the R992C Pro-GFP variant and two 
different clones expressing the R992C Pro-GFPTet variant revealed that the relative amount of 
cleaved PARP increased in cells harboring the R992C mutant (Fig. 8). Specifically, in the cells 
harboring the R992C Pro-GFP variant, the relative amount of cleaved PARP increased 2.2-fold 
in comparison to control (P=0.009). Moreover, in comparison to control, the relative amount of 
cleaved PARP after induction with Dox increased 2.8-fold (P=0.004). In contrast, in cells 
expressing the WT Pro-GFP adding Dox did not increase the relative amount of cleaved PARP 
(P=0.756).  
 
Measurements of selected indicators of ER stress. 
 We employed Western blot assays to analyze selected indicators of ER stress. As shown in 
Fig. 9, the relative amount of PDI in cells expressing the R992C Pro-GFP variants increased 2.3-
fold in comparison to control (P=0.032). Analysis of Pro-GFPTet system also revealed that the 
Dox-induced R992C Pro-GFPTet variant increased the relative amount of PDI 1.9-fold 
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(P=0.0004), while Dox-induced WT Pro-GFPTet did not show any significant difference 
(P=0.839). Western blotting of BiP also revealed a similar trend, although the 2.4-fold increase 
in the relative amount of BiP in the R992C Pro-GFP variant was not statistically significant 
(P=0.215) (Fig. 9). However, the 3.2-fold increase in the BiP content in Dox-stimulated cells 
expressing the R992C Pro-GFPTet was statistically significant (P=0.003).  
 
Analysis of LH and P4H. 
 We studied whether the presence of the mutant α1(II) chains could be associated with 
increased expression of LH and P4H. Our analyses revealed that the relative amounts of LH (Fig. 
9) and the α-subunit of P4H (P4Hα; not shown) in cells expressing the R992C mutant were 
similar to that of control.  
 
In situ colocalization of BiP, PDI, and P4H with the R992C Pro-GFP. 
 To examine the potential interaction of selected chaperones with mutant collagen II in situ, 
we employed fluorescence microscopy to analyze colocalization of BiP and PDI with WT Pro-
GFP and R992C Pro-GFP variants (Fig. 10). Considering that PDI functions not only 
independently as protein disulfide-isomerase but also acts as the β-subunit of P4H, we studied 
the colocalization of the α-subunit of this enzyme with Pro-GFP variants. These studies were 
critical for determining whether in response to the presence of mutant collagen II, PDI interacted 
with Pro-GFP variants independently or as a member of the αα/ββ P4H complex. To describe 
colocalization of BiP/Pro-GFP, PDI/Pro-GFP and P4Hα/Pro-GFP we used the overlap 
coefficient (R), a value that ranges from 0 and 1 and is not sensitive to variations in pixel 
intensities. We demonstrated that in comparison to the cells expressing WT Pro-GFP 
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(R=0.61±0.015; N=66) the overlap coefficient for PDI/Pro-GFP colocalization was higher in 
cells expressing the R992C Pro-GFP (R=0.72±0.010; N=69). Moreover, we analyzed BiP/Pro-
GFP colocalization, and our study determined that in comparison to cells expressing WT Pro-
GFP (R=0.28±0.012; N=40) the value for the overlap coefficient decreased in cells expressing 
R992C Pro-GFP (R=0.14±0.009; N=43). Statistical analysis determined that the differences in 
the R values for PDI/Pro-GFP and BiP/Pro-GFP colocalization were statistically significant with 
P<0.0001. In addition, we determined that, in comparison to PDI and BiP, the overlap 
coefficient for P4Hα/Pro-GFP colocalization was relatively low for cells expressing WT Pro-
GFP (R=0.16±0.009; N=39), and it did not significantly change (P=0.8) in cells expressing the 
R992C Pro-GFP variant (R=0.15±0.008; N=30). 
 
 
Discussion 
 
 Contrary to the mutations in the “G” and “Y” positions, the molecular and cellular-level 
consequences of the “X” position amino acid substitutions in collagen II have not described. 
Here, we studied the molecular and cellular effects of the “X” position R992C substitution in 
collagen II found in mice with pathological skeletal features resembling those of SED 24. More 
recently, we presented evidence that in the growth plates of these mutant mice chondrocytes 
include dilated ER cysternae and the number of cells undergoing apoptosis is higher than in 
control 23. The molecular bases of such cellular changes, however, were not determined 23.  
 In the present study we showed that α1(II) chains of collagen II with the R992C substitution 
are characterized by relatively slow electrophoretic mobility and the existence of intramolecular 
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disulfide bonds. Relatively slow electrophoretic mobility of the mutant α1(II) chains was not a 
result of their excessive glycosylation. Because the electrophoretic mobility of fibrillar collagens 
does not strictly follow principles that govern migration of globular proteins, it is difficult to 
fully explain the aberrant behavior of the R992C mutant. We postulate, however, that the 
delayed electrophoretic mobility of the R992C mutant in the absence of evident chemical 
overmodifications could be a result of its structural alterations. In support of this notion is the 
report by Forlino et al. where delayed mobility of α2(I) chains harboring G421D substitution in 
the absence of the overmodifications was attributed to a structural change represented by a kink 
formed in some mutant collagen I molecules 27. Moreover, in our own studies on R789C 
collagen II we observed structural aberrations and determined that the electrophoretic mobility of 
this mutant was slower than that of wild type collagen II 28. 
 Consequences of structural aberrations of the R992C collagen molecules include their slow 
secretion from cells, lower thermostability, and formation of intramolecular disulfide bonds 
between about 6% of the α1(II) chains. Formation of disulfide bonds in the R75C, R519C, and 
R789C collagen II mutants isolated from patients’ tissues or in corresponding recombinant 
mutants expressed in HT-1080 cells was also reported 15,19,28,29. A common characteristic of 
those mutants is that, unlike in the R992C collagen, the C for R substitutions occur at the “Y” 
positions of G-X-Y triplets.  
 Structural aberrations of the R992C collagen II are further illustrated by the formation of 
stable intermediate products of the digestion of this protein with trypsin and chymotrypsin. In 
accordance with the concept of micro-unfolding of a collagen triple-helix, it has been suggested 
that the presence of such intermediate products is evidence for the destabilization of cooperative 
blocks 30,31. As suggested by Westerhausen et al., certain amino acid substitutions may expose 
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trypsin/chymotrypsin-sensitive sites at relatively low temperatures, thereby leading to the 
generation of intermediate collagen fragments of varying sizes 31. The 1°C-decrease in 
thermostability (Tm50) in the R992C mutant is relatively small in comparison to the 5°C-
decrease of thermostability in the R789C mutant 28. It is expected, however, that the change of 
the triple helix-stabilizing arginine residue to the triple helix-destabilizing cysteine residue is 
significant for the overall structure and physicochemical characteristics, such as the electrostatic 
potential, and the stability of the region encompassing the mutation site 32. In particular, the 
R992C substitution may interfere with functions of the neighboring C-terminal triple-helix-
stabilizing “knot” that is formed by tandem repeats of triple helix-stabilizing G-P-P triplets 33. 
 In our previous studies on collagen II mutants we observed that, in contrast to thermostable 
R75C, R519C, and G853E mutants, the thermolabile R789C mutant was associated with 
apoptosis of host cells. The direct role of this mutant in triggering the apoptotic changes was 
demonstrated in chondrocytic cells in which the production of the R789C Pro-GFPTet was 
induced by Dox. Here, we also employed a Tet-inducible system for expressing the R992C Pro-
GFPTet, and our results indicate that the presence of this mutant is directly responsible for the 
increase in the number of cells undergoing apoptosis. In comparison to the R789C mutant, 
however, the relative content of cleaved PARP, an indicator of apoptosis, was significantly lower 
in cells expressing the R992 Pro-GFP or R992C Pro-GFPTet variants. A less severe apoptotic 
response of the chondrocytic cells expressing the exogenous R992C collagen II together with 
endogenous wild type collagen II could explain the observation that SED-like characteristics of 
skeletal tissues were only apparent in sedc mice expressing the mutant Col2a1 in a homozygous 
way 24. Still, we postulate that the possibility of mild aberrations at molecular and cellular levels 
in heterozygous sedc mice cannot be completely excluded. 
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 Because of the apparent increase in the expression of BiP and PDI in response to the 
presence of the R992C collagen II, our study suggests activation of the unfolded protein response 
process in cells expressing this thermolabile mutant. In addition to the increase in the 
biosynthesis of PDI, we also demonstrated increased in situ colocalization of this chaperone with 
the R992C Pro-GFP. Because PDI not only functions independently but also serves as the β-
subunit of the αα/ββ tetramer which constitutes functional P4H, we studied the specificity of the 
increase in the biosynthesis of PDI and its elevated colocalization with R992C Pro-GFP. Our 
studies with the anti-P4Hα antibodies determined that, in comparison to cells expressing WT 
Pro-GFP, the quantity of P4H and its colocalization with R992C Pro-GFP did not change. These 
observations suggest that, in response to the presence of the R992C mutant, PDI enhances rather 
its chaperone roles than its P4H-related functions. The increased colocalization of PDI with 
R992C Pro-GFP may indicate an increase in the PDI/R992C Pro-GFP binding. Such a notion is 
justified by observations that PDI preferably binds to the nascent procollagen α chains, but it 
may remain bound even after the α chains fold into a triple-helical structure 2,34. As 
demonstrated with certain collagen I mutants, PDI facilitates intracellular retention of aberrant 
collagen molecules by binding to misfolded α chains. Such PDI-mediated retention of the 
R992C Pro-GFP is suggested by its slow rate of secretion from the host cells.  
 In contrast to PDI, in situ colocalization of BiP decreased in the cells expressing the R992C 
mutant. The role of BiP in retention of misfolded protein molecules is less clearly defined and 
somewhat controversial 3,35. Based on the studies of collagen I and collagen II mutants, it has 
been suggested that this molecule interacts with collagen weakly, and it preferably binds to the 
triple-helical structure of the collagen molecule 3,23.Thus, we propose that the decrease in 
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colocalization of the R992C Pro-GFP with BiP could be a result of altered triple-helicity of the 
BiP-binding regions, blocking of the BiP-binding sites by PDI, or both. 
 Our studies presented here indicate that pathomechanisms responsible for altering skeletal 
tissues harboring single amino acid substitutions in collagen II include those that function at the 
intracellular level. In the future, detailed studies of biological processes triggered by the presence 
of mutant collagen molecules will reveal specific pathways that lead from altered collagen 
structure to the apoptosis of affected cells. Understanding such pathways will be critical for 
determining a genotype/phenotype relation in heritable diseases caused by mutations in genes 
that encode fibrillar collagens. 
 
 
Materials and Methods 
 
Mutation nomenclature. 
 The amino acid substitutions are named according to the literature, with amino acid residues 
numbered from the first glycine of the collagen II triple helix. At their initial text appearances the 
mutations are also numbered from the ATG start codon following the journal and the Human 
Genome Variation Society guidelines (www.hgvs.org) and are listed in parentheses (with a “p” 
included in the mutation name). 
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Engineering cDNA constructs for unconditional and Tet-regulated expression of GFP-tagged 
procollagen II variants. 
 Although the R992C substitution was originally described in mice, to study the 
consequences of this mutation at the molecular level, we employed a system that utilizes human 
collagen II. Such an approach is justified because of the high similarity between amino acid 
sequences of mouse (NP_112440.1) and human collagen II (NP_001835.3); in the region 
encompassing the mutation site, this similarity is 100%. A DNA construct for expression of the 
procollagen II mutant with the R992C substitution was assembled from DNA cassettes which 
encode specific domains of human procollagen II, as described 21,36,37. In particular, a DNA 
construct was created by mutating the –CGA- codon for R992 to the –TGC- codon for C992 
(Quick Change mutagenesis kit, Stratagene, Inc.). 
 For the unconditional expression of the GFP-tagged R992C procollagen II, denoted as 
R992C “Pro-GFP”, a DNA construct was cloned into the pEGFP-N3 vector (Clontech 
Laboratories, Inc.), as described 22. In addition, to study the specific biological responses of cells 
to the presence of the R992C mutant, we employed a conditional expression system in which the 
expression of GFP-tagged procollagen II variants, denoted as “Pro-GFPTet”, was regulated by a 
Tet-responsive promoter (Clontech Laboratories, Inc.), as described 23. The fidelity of all DNA 
constructs was determined by sequencing. 
 
Analysis of procollagens and collagens variants expressed in HT-1080 cells. 
 To obtain procollagen II for protein analyses, the WT Pro-GFP and the R992C Pro-GFP 
variants were expressed in HT-1080 cells (ATCC, CCL-121), as described 25. These procollagen 
II variants were isolated from cell culture media and purified by ion exchange chromatography, 
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as described 25. Because the R992C procollagen II variant was relatively unstable and over time 
underwent partial degradation, for analyses of collagen II variants, procollagen secreted to cell 
culture media was precipitated with ammonium sulfate, as described. Pellets were suspended in 
0.5 M acetic acid and then dialyzed against this solvent. Acetic acid-insoluble material was 
removed by centrifugation, and then proteins were digested for 48 h at 4°Cwith pepsin (Sigma-
Aldrich) added to the final concentration of 0.1 mg/ml. Pepsin-resistant collagen was precipitated 
with 0.7 M NaCl and then collected by centrifugation. 
 
Analysis of intact Pro-GFP and pepsin-processed collagen variants. 
 Freshly isolated intact procollagen II variants secreted to cell culture media and pepsin-
treated collagens were analyzed by electrophoresis. To visualize any potential differences in the 
electrophoretic mobilities of analyzed proteins, electrophoresis was carried out in 6% 
polyacrylamide gels and continued until a 50-kDa molecular mass marker had reached the lower 
edge of polyacrylamide gels. To facilitate specific detection of relatively small amounts of 
analyzed proteins, intact Pro-GFP variants were transferred to nitrocellulose membranes and 
visualized by immunostaining with anti-GFP antibody (Santa Cruz Biotechnology, Inc) and 
secondary anti-mouse IgG conjugated with horseradish peroxidase (HRP, Sigma-Aldrich). 
Specific bands were visualized by chemiluminescence (UVP, LLC). Similarly, pepsin-treated 
collagens were detected with anti-collagen II antibody (Millipore). Note that neither antibodies 
cross-react with proteins secreted from untransfected HT-1080 cells. 
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Treatment of collagen II with selected glycosidases and denaturing agents. 
 To determine if delayed electrophoretic migration of the mutant α1(II) chains could be a 
result of their overglycosylation, we employed neuraminidase, N-glycosidase F, and endo-α-N-
acetylgalactosaminidase (New England BioLabs, Inc.) to remove collagen-bound carbohydrates 
25
. After treatment with selected enzymes, α1(II) chains were electrophoresed in polyacrylamide 
gels and the extents of their electrophoretic migrations were evaluated. 
 To exclude the possibility that the delayed migration of the R992C collagen II could be a 
result of its aggregation, we treated this mutant with selected agents that promote the dissociation 
of macromolecular complexes. Specifically, we employed 4 M urea, 4 M guanidinium 
hydrochloride, 0.5 M acetic acid or 50% dimethyl sulfoxide. Individual samples of wild type and 
R992C mutant were treated with these compounds for 48 h. Subsequently, electrophoretic 
migrations of collagen samples were analyzed.  
 
Analysis of disulfide bonds. 
 The intramolecular disulfide bonds formed between the C992 residues were assayed by 
electrophoresis.  In brief, initially  the α-chains of pepsin-treated collagen II were separated in 
7.5% polyacrylamide gels under non-reducing conditions. Subsequently, gel strips with 
separated α-chains were cut and submerged for 1 h in a protein-loading buffer supplemented 
with β-mercaptoethanol. Next, the gel strip was placed horizontally on the top of a new 
polyacrylamide gel and electrophoresis was carried out. Finally, protein bands were transferred 
to nitrocellulose membranes and the α1(II) chains were specifically detected by Western blot as 
described above. 
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Analysis of the conformational integrity of the R992C collagen II. 
 The thermostability of the R992C collagen was measured by brief protease digestion, as 
described 38. In brief, the pepsin-treated samples dissolved in a 0.1 M Tris-HCl buffer (pH 7.4) 
supplemented with 0.4 M NaCl and 25 mM EDTA were pre-incubated for 30 min at selected 
temperatures and then treated for 3 min with a mixture of trypsin (100 µg/ml, Sigma-Aldrich) 
and chymotrypsin (250 µg/ml, Sigma-Aldrich). Enzymatic digestion was terminated by adding 
0.1-volume of 5 mg/ml soybean trypsin inhibitor (Sigma-Aldrich). Protease-treated collagen 
samples were electrophoresed in reducing conditions in 7.5% polyacrylamide-SDS gels and then 
the protein bands were transferred to nitrocellulose membranes and analyzed by Western blot as 
described above. Relative amounts of the protease-resistant α1(II) chains in analyzed samples 
were determined by measuring the pixel intensities of the α1(II)-positive bands. Considering the 
relative value of the intensity of an α1(II) band derived from collagen digested at 30°C a 100%, 
the relative values of the intensities of α1(II) bands derived by enzymatic digestion at higher 
temperatures were measured. The mean values from three independent experiments were 
calculated and plotted against temperature (Sigma Plot v. 8.02, SPSS Inc.) 
 
Computer modeling of the R992C mutation site. 
 A computer model of the triple-helical region spanning the R992C mutation site was 
generated by the Sybyl7.3 program (Tripos, Inc.) as described 18,39. Molecular surfaces of the 
analyzed collagen fragments were generated using the MOLCAD module of the Sybyl program 
20,40
. The same module was used to calculate electrostatic potential (EP, physical unit; 
kcal/mol.e) and the area of the analyzed surfaces 41. 
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Unconditional and Tet-regulated expression of Pro-GFP and Pro-GFPTet variants in SW-1353 
cells. 
 The WT Pro-GFP and R992C Pro-GFP variants were unconditionally expressed in the 
chondrocytic SW-1353 cell line (ATCC; HTB-94), as described 22,23. This cell line was also 
employed to express the WT Pro-GFPTet and R992C Pro-GFPTet variants in the Tet-dependent 
fashion, as described 23. Selected SW-1353 clones stably expressing Pro-GFP or Pro-GFPTet 
variants were cultured in Dulbecco's Modified Eagle’s Media (DMEM) supplemented with 10% 
fetal bovine serum (FBS) or Tet-system-certified FBS (Clontech Laboratories, Inc.) and 40 
µg/ml of L-ascorbic acid phosphate magnesium salt (Wako, Japan). Expression of the Pro-
GFPTet variants was initiated by culturing the Tet-responsive SW-1353 cells in the presence of 1 
µg/ml of doxycycline (Clontech Laboratories, Inc.). Biosynthesis of Pro-GFP and Pro-GFPTet 
variants in selected SW-1353 clones was confirmed at the mRNA and protein levels, as 
described 22,23. Moreover, the kinetics of secretion of analyzed Pro-GFP variants were studied, as 
described 22.  
 
TUNEL and cleaved PARP assays. 
 Confluent cells expressing Pro-GFP and Pro-GFPTet variants were cultured for 12 days and 
then analyzed for the markers of apoptosis, as described 23. In one set of experiments the 
presence of fragmented DNA was analyzed by TUNEL assays (Roche). In these analyses 
untransfected SW-1353 cells treated with 3 units/ml of DNaseI (Sigma-Aldrich) served as a 
positive control. The cells were observed under a fluorescence microscope (Eclipse E600; 
Nikon) equipped with appropriate filter sets and a monochromatic digital camera (CoolSnap CF; 
Photometrics, Inc.) controlled by Image-Pro AMS software (version 5.1.0.2.0, Media 
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Cybernetics, Inc). The total number of cells in viewing areas was determined by DAPI-positive 
nuclei. Subsequently, the percentage of TUNEL-DAPI-positive cells in analyzed groups was 
calculated 23. 
 In addition to the TUNEL assays, Western blot analyses of cleaved PARP were employed to 
identify apoptosis, as described 23. In these assays cleaved PARP was detected with primary 
rabbit anti-cleaved PARP antibodies (Cell Signaling Technology, Inc.) and secondary anti-rabbit 
IgG conjugated to HRP (Sigma-Aldrich). Employing a gel imaging system (UVP, LLC), bands 
corresponding to the cleaved PARP were visualized by chemiluminescence. The same 
nitrocellulose membranes were also probed with monoclonal anti-glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) antibodies (Santa Cruz Biotechnology, Inc.). Relative amounts of 
cleaved PARP in analyzed samples were determined by measuring the pixel intensities of the 
cleaved PARP-positive bands. To correct densitometry data for any differences in loading the 
samples onto polyacrylamide gels, final calculations were done assuming equal content of 
GAPDH in all analyzed samples. The ratio of relative amount of cleaved PARP from cells 
expressing the R992C Pro-GFP to cleaved PARP from cells expressing WT Pro-GFP was 
calculated. In experiments with Pro-GFPTet variants, the ratio of relative amount of cleaved 
PARP from Dox-induced cells to that from corresponding non-induced cells was calculated. 
Statistical significances of differences between the calculated means were analyzed by the 
Student’s t test (GraphPad Software, Inc.). 
 
Measurements of selected indicators of ER stress. 
 It has been shown that some mutations in fibrillar collagens are associated with increased 
expression of chaperones such as BiP and PDI 2,3,23. To specifically determine whether ER 
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stress-related changes in the relative amounts of these proteins were caused by the presence of 
the R992C mutant, we employed cells expressing R992C Pro-GFP and R992C Pro-GFPTet 
variants. The presence of intracellular BiP and PDI was analyzed by Western blot assays with rat 
monoclonal anti-BiP and goat anti-PDI antibodies (Santa Cruz Biotechnology, Inc), respectively. 
Consistent with other Western blot assays GAPDH-positive bands served as the internal control. 
 
Analysis of LH and P4H. 
 Analysis of LH (EC 1.14.11.4) and P4H (EC 1.14.11.2) in lysates from cells expressing Pro-
GFP variants was done by Western blot assays. Primary goat anti-LH antibodies (Santa Cruz 
Biotechnology, Inc.) and secondary donkey anti-goat IgG antibodies conjugated to horseradish 
peroxidase (HRP; Rockland Immunochemicals) were used to detect LH-specific bands. Primary 
rabbit antibodies against the α1 subunit of P4H and HRP-conjugated secondary anti-rabbit IgG 
were employed to detect the P4Hα-specific bands (Sigma-Aldrich). In these assays GAPDH 
served as internal control and was detected as described above. 
 
Fluorescence microscopy assays of in situ colocalization of the R992C Pro-GFP with BiP, 
PDI, and P4H. 
 It has been shown that in response to the ER stress, BiP and PDI function as chaperones by 
binding to the misfolded mutant collagen molecules, thereby facilitating their intracellular 
retention. To determine the potential involvement of BiP and PDI in controlling intracellular 
retention and folding of the R992C collagen, we assayed the colocalization of these interacting 
partners. We also analyzed whether during ER stress PDI interacts with Pro-GFP variants 
independently or as the β-subunit of P4H. In these assays we studied colocalization of Pro-GFP 
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variants with the catalytical α-subunit of the P4H. In previous studies we analyzed possible Pro-
GFP/BiP and Pro-GFP/PDI binding by co-immunoprecipitation assays 23. Because the studied 
interactions are weak, these assays are complex and require employing a cross-linking compound 
that prevents dissociation of interactants in the detergent-rich environment of a cell lysis buffer. 
Thus, in this study intracellular colocalization of the R992C Pro-GFP with BiP, PDI, and P4Hα 
was assayed after immunostaining of these specific binding partners with rabbit anti-BiP (Santa 
Cruz Biotechnology, Inc.), rabbit anti-PDI (Santa Cruz Biotechnology, Inc.) or rabbit anti-
P4Hα antibodies (Sigma-Aldrich), respectively. Specific secondary antibodies conjugated with 
Alexa Fluor 594 were employed to visualize intracellular localization of analyzed proteins 
(Invitrogen, Inc.). At first, the cells were permeabilized with 0.2% Tween 20 and then the 
samples were blocked with appropriate serum to minimize non-specific binding of antibodies. 
Subsequently, the samples were incubated with primary and then secondary antibodies at 
conditions optimized in pilot studies. Finally, nuclei were stained with DAPI and the samples 
were mounted with a mounting media reagent (Prolong Gold; Invitrogen, Inc.). To determine the 
extent of nonspecific immunostaining and the degree of autofluorescence, samples treated only 
with secondary antibodies and those with no antibody treatment were prepared as controls. 
 The immunostained cells were observed with a microscope (Eclipse E600, Nikon, Japan) 
equipped with a computer-controlled Z-stack stage and sets of chromophor-specific filters and 
the Plan Fluor 40x/1.3 Oil objective (Nikon, Japan). Images of the cells were acquired with a 
monochromatic digital camera (CoolSnap CF; Photometrics, Inc.) controlled by Image-Pro AMS 
software (version 5.1.0.2.0, Media Cybernetics, Inc). Control samples were employed to correct 
for the background fluorescence. Pairs of images taken with filters specific for GFP and Alexa 
Fluor 594 were pseudo-colored and then merged. Following deconvolution, colocalization of 
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pixels from green and red channels was measured by using the “Colocalization Module” of the 
Image-Pro AMS software. Colocalization of pixels from a cytoplasm region of analyzed cells 
was expressed as the overlap coefficient (R). This parameter, defined by Manders et al., 
represents a true degree of colocalization of defined pixels and is not sensitive to the limitations 
of typical fluorescence imaging, such as efficiency of hybridization, sample photobleaching, and 
camera quantum efficiency 42. 
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FIGURE LEGENDS 
Figure 1. Analysis of intact and processed R992C Pro-GFP.  
 A: Western blot assays of WT Pro-GFP and R992C Pro-GFP variants freshly isolated from 
cell culture media and electrophoresed in 6% polyacrylamide gels. B: Analysis of pepsin-
processed collagen II variants after their treatment with glycosidases. Note that after 
electrophoresis in a 7.5% gel only a relatively small shift in migration was seen after glycosidase 
treatment. Symbols: WT Pro-GFP and WT, wild type procollagen II and collagen II, 
respectively; R992C Pro-GFP and R992C, procollagen II and collagen II mutant harboring 
R992C substitution, respectively; Pro-α1-GFP, GFP-tagged procollagen chains; α1, pepsin-
treated collagen chains; +/- indicates the presence or the absence of glycosidases (Glyc) in 
analyzed samples; asterisks in panel B indicate partially degraded mutant collagen. Positions of 
molecular mass markers and types of antibodies employed in detecting procollagens and 
collagens are also indicated. 
 
Figure 2. Analysis of disulfide bonds formed between α1 chains of the R992C mutant.  
A: Analysis of the WT collagen variant. B: Analysis of disulfide-linked α1 chains present in the 
R992C collagen II. Collagen II was separated in non-reducing conditions in a 7.5% 
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polyacrylamide gel (left panel). Next, a gel strip with separated collagen chains was cut and 
submerged in the reducing agent. Subsequently, the gel strip was placed at the top of another 
7.5% gel. After electrophoresis, collagen bands were detected with anti-collagen II antibodies. 
Symbols: WT, wild type collagen II; R992C collagen II mutant harboring R992C substitution; 
α1 and S-Sα1, single collagen chains and disulfide-linked chains; (+/-) β indicates the presence or 
the absence of β-mercaptoethanol in analyzed samples; arrows in panel B indicate direction of 
electrophoretic migration of analyzed collagen. 
 
Figure 3. Assays of the thermostability of the R992C mutant. 
 Followed preincubation at increasing temperatures, collagen II samples were subjected to 
brief proteinase digestion. The digested samples were electrophoresed in 7.5% polyacrylamide 
gels in reducing conditions and then α1(II) chains were visualized by Western blot (A). 
Subsequently, the relative pixel intensities of α1(II) chains were measured by densitometry. A 
graphic representation of changes in the relative amount of triple-helical collagen II in response 
to increasing temperature is shown in the panel B. Symbols: WT, wild type collagen II; R992C, 
collagen II mutant harboring R992C substitution; α1, α1(II) chains; α1 Int, intermediate 
products of enzymatic cleavage of the α1(II) chains; closed circles represent WT while open 
circles represent the R992C mutant.  
 
Figure 4. A computer model of the region encompassing the R992C mutation site.  
 Surfaces representing electron densities were generated using a computer program. The left 
panel illustrates the electrostatic potentials (EP) of regions encompassing R992 and C992 sites. 
The right panel is a front view at the mutation site (indicated by a plane in the left panel). 
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Relatively large surface with the EP values similar to those of the R992 site present in the WT 
collagen is significantly reduced in the R992C mutant. The intramolecular disulfide bond formed 
between C992 residues is indicated with two asterisks while the free C992 residue is indicated 
with one asterisk. R990 and E995 residues neighboring the mutation site are indicated for 
reference. Legend: Color code used to indicate differences in the EP: red, highly positive EP; 
blue, highly negative EP. 
 
Figure 5. Constant production of the Pro-GFP variants and Dox-dependent production of Pro-
GFPTet variants by SW-1353 cells.  
 A: RT-PCR assays of Pro-GFP expression and Dox-dependent expression of Pro-GFPTet 
variants. In all samples, analyses of GAPDH were employed as controls. B: Western blot 
analysis of Pro-GFP and Pro-GFPTet variants extracted from cells cultured in the absence (-) or 
presence (+) of Dox. Note: All procollagen II-GFP chimeras were detected with anti-GFP 
antibody. In the same samples GAPDH was detected with anti-GAPDH antibody. Symbols: WT, 
samples that include wild type procollagen II; R992C, samples that include R992C collagen II; 
Pro-GFP, cells that unconditionally express procollagen II-GFP chimeras; Pro-GFPTet, cells that 
express procollagen II-GFP chimera whose expression is Tet-dependent; Dox +/- indicates the 
presence or absence of Dox in cell culture media.  
 
Figure 6. Kinetics of secretion of procollagen II variants from SW-1353 cells.  
 A: Western blot assays of secretion of Pro-GFP variants with anti-GFP antibody. B: Graphic 
representation of rates of secretion of analyzed Pro-GFP variants. Mean values of the relative 
intensities of protein bands were derived from three independent measurements. For the R992C 
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Pro-GFP, data from two different clones were included. For both, the WT and R992C variants 
the pixel intensity values at the indicated time points were calculated as a percent of the value for 
the WT Pro-GFP measured at the 6th hour. Note that the intensity of WT Pro-GFP at 6th hour is 
considered 100%. Symbols: WT, samples that include wild type collagen; R992C, samples that 
include R992C mutants. 
 
Figure 7. TUNEL assays of apoptosis in cells expressing type II collagen mutants. 
 A: A representative image of nuclei of cells analyzed by TUNEL. DAPI-stained nuclei 
(left), TUNEL-positive nucleus (center) and merged images of both (right) are presented. 
B: A graphic representation of apoptotic indexes in cells expressing the Pro-GFP variants and the 
Pro-GFPTet variants cultured in the absence (-) or presence (+) of Dox. The apoptotic index is 
defined as the percentage of TUNEL-positive nuclei out of the total number of DAPI-positive 
nuclei. Note: Quantitative results for the R992C mutant are based on measurements of two 
independent clones. Symbols: WT, cells that express wild type collagen II; R992C, the R992C 
collagen II mutant; Dox (+/-), the presence or absence of Dox in cell culture media.  
 
Figure 8. Assays of cleaved PARP in cells expressing Pro-GFP and Pro-GFPTet variants.  
A: Western blot assays of cleaved PARP in cells expressing Pro-GFP and Pro-GFPTet variants. 
B: Analysis of relative amounts of cleaved PARP in cells expressing Pro-GFP variants and Pro-
GFPTet variants. On the left, the ratio of the cleaved PARP present in cells expressing the R992C 
Pro-GFP mutant to the cleaved PARP in cells expressing the WT Pro-GFP variant is presented. 
Mean values and standard errors of means (in parentheses) are presented. Statistical significances 
of differences between means and the number of independent measurements are also indicated. 
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On the right, analyses of the relative amounts of cleaved PARP in cells expressing Pro-GFPTet 
variants before (-) and after (+) Dox induction. The changes were calculated as ratios of cleaved 
PARP present in induced and non-induced cells. Mean values and standard errors of means (in 
parentheses) are presented. Statistical significances of differences between means and the 
number of independent measurements are also indicated. Note: Quantitative results for the 
R992C mutant are based on measurements of two independent clones. Symbols: WT, cells that 
express wild type collagen II; R992C, samples that include the R992C collagen II mutant; Pro-
GFP, cells that unconditionally express the respective collagen II variant; Pro-GFPTet, cells that 
express the respective collagen II variant in the Tet-dependent fashion; Dox (+/-), the presence or 
absence of Dox in cell culture media; cPARP, cleaved PARP; GAPDH, GAPDH-positive bands. 
 
Figure 9. Assays of chaperones in cells expressing Pro-GFP and Pro-GFPTet variants.  
A and B: Assays of PDI in cells expressing Pro-GFP and Pro-GFPTet variants. C and D: Assays 
of BiP in cells expressing Pro-GFP and Pro-GFPTet variants. E and F: Assays of LH in cells 
expressing Pro-GFP and Pro-GFPTet variants. In each graph, the ratios of chaperones present in 
cells expressing Pro-GFP mutants to chaperones in cells expressing WT Pro-GFP are presented. 
Mean values and standard errors of means (in parentheses) are presented. Statistical significance 
of differences between means and the number of independent measurements are also indicated. 
Moreover, in each graphic panel analyses of the relative amounts of chaperones in cells 
expressing Pro-GFPTet variants before (-) and after (+) Dox induction are presented. The changes 
were calculated as ratios of chaperones present in induced and non-induced cells. Mean values 
and standard errors of means (in parentheses) are presented. Statistical significance of 
differences between means and the number of independent measurements are also indicated. 
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Note: Quantitative results for the R992C mutant are based on measurements of two independent 
clones. Symbols: WT, cells that express the wild type collagen II; R992C, samples that include 
the R992C mutant; Pro-GFP, cells that unconditionally express the respective collagen II variant; 
Pro-GFPTet, cells that express the respective collagen II variant in the Tet-dependent fashion; 
Dox (+/-), the presence or absence of Dox in cell culture media; LH, Lysyl hydroxylase-positive 
bands; GAPDH, GAPDH-positive bands. 
 
Figure 10. Colocalization of Pro-GFP with BiP, PDI, and P4H.  
 Representative images of cells expressing the R992C Pro-GFP and immunostained for BiP, 
PDI or P4H are presented. Red channels, green channels and mergers of both together with 
DAPI-stained nuclei are depicted. 
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